Atara Biotherapeutics, Inc. (ATRA)
NASDAQ · Healthcare
Atara Biotherapeutics, Inc. Operating Income 2022–2025
Atara Biotherapeutics, Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Atara Biotherapeutics, Inc. operating income for the quarter ending March 31, 2026 was -3.4 M, a 108.68% decrease year-over-year.
- Atara Biotherapeutics, Inc. operating income for the twelve months ending March 31, 2026 was 35.1 M, a 124.89% decrease year-over-year.
- Atara Biotherapeutics, Inc. annual operating income for 2025 was 35.9 M, a 142.98% decrease from 2024.
- Atara Biotherapeutics, Inc. annual operating income for 2024 was -83.4 M, a 69.77% decrease from 2023.
- Atara Biotherapeutics, Inc. annual operating income for 2023 was -276.0 M, a 1.61% decrease from 2022.
- Atara Biotherapeutics, Inc. annual operating income for 2022 was -280.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Atara Biotherapeutics, Inc. Operating Income — FAQ
Atara Biotherapeutics, Inc. (ATRA) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Atara Biotherapeutics, Inc.'s operating income?
Atara Biotherapeutics, Inc. (ATRA) reported operating income of $36M for fiscal 2025.
Where can I see ATRA's operating income history?
The chart and table above show Atara Biotherapeutics, Inc.'s operating income by year and by quarter, including the growth rate.